Hepatitis C And The Silent Epidemic

This research paper is going to review today’s silent killer, the Hepatitis C virus. This paper will talk about the description of the disease, the signs and symptoms, the etiology and risk factors, diagnostic studies, treatments and prognosis of this disease. I had lived with this disease for over ten years before diagnosed so it is important to understand the signs and symptoms so the disease can be identified and a treatment plan can be identified as the sooner it is treated the more likely it will eradicate the disease.

The Never event: Exposing the largest outbreak of hepatitis c in American healthcare history (McKnight & Bennington, 2008) begins telling the story of what should have been a “top-notch” cancer center with a doctor committed to saving lives. Memorial Hospital of Dodge County was expanding their cancer services, making access to services easier for the community. They wanted to keep their patients in town and help them avoid commutes to Omaha. They hired Dr. Tahir Ali Javed from Punjab, Pakistan; he educated and trained at well-known, prestigious facilities. Everything that was put into place, the new facility and outstanding physician, made it seem as though the cancer center was going to exceed the expectations that the hospital had in mind. However, malpractice, lack of compassion, and avoidance drove the center and the patients into the ground. After reading this novel, I was able to define compassionate care in my own terms and will provide examples of acts of compassionate care. As well as, discussing the principles of dignity and beneficence in regards to Dr. Javed and nurses in the clinic. Lastly, I will provide a testimony statement about the future care of patients.

HCV is known as the "silent killer" due it's long duration on the liver for 20-30 years (Hirsch, 2000).

As alarming as this may sound, this does affect you in your daily lives. A majority of the people reading this piece may be healthy beings, but there are no guarantees that this may not affect us in the future. Then again, other than hepatitis C, there are numerous other illnesses such as rheumatoid arthritis that we may encounter later in our lives. These diseases also have an alarming price tag associated with its treatments or medications.

About 4.1 million people in Americans have the positive antibody to hepatitis C virus (HCV), and about 75 percent have permeant infection. Additionally, most of the infections happened 20 to 40 years ago, before the finding of HCV. Hepatitis C increased from 7,000 to 13,000 deaths in 2005. Furthermore, HCV develops slowly which increases the risk of severe complications in the infected people. Identification, death, and treatment are predicted to affect 35,000 by 2030. The Center for Disease Control (CDC) used antiviral therapy with PEGylated in clinical trials (Kalichman, Washington, Kegler, Grebler, Kalichman, Cherry, & Eaton, 2015). The CDC recommends a HCV one time test for people born between 1945 and 1965. The objective of this study was to thoroughly evaluate the amount of substance abusers infected with hepatitis C in the United States. Additionally, to observe the treatment of HCV. Currently Medicaid and Medicare repayment standards for sofosbuvir were calculated in all states, including the District of Columbia. Medicaid and Medicare covered the drug based on the following conditions; liver disease stage, HIV, and drug use. Approximately 42 states reimbursed the following criteria up to 74 percent for the drug sofobuvir. About two-thirds of the United States restricted the treatment centered on prescriber type. About 88 percent included drug abuse in their sofosbuvir admissibility measures. Finally, 50 percent required a date of abstinence and 64 percent required

Many people don’t understand how dangerous Hepatitis C is because it is not commonly known about as much as Hepatitis A or B. This disease is however very serious. Although frequently asymptomatic in time the virus can lead to cirrhosis, liver cancer and liver failure. Symptoms of HCV are jaundice (yellowing of the eyes), stomach pain, nausea and fatigue. Treatment options for the disease, if caught early enough is a combination of medications or depending on the degree of damage, a liver transplant. ”For some people, hepatitis C is a short-term illness but for 70%-85% of people who become infected with

14-Hepatitis C- is a slow-developing disease that can lead to liver damage and liver cancer as many as 30 years after infection. Remission can occur in up to 15 percent of people infected with HCV and four percent of infected people die from the virus.

About 4.1 million people in Americans have the positive antibody for hepatitis C virus (HCV), and about 75% of them are persistently infected and most of the infections happened d 20 to 40 years ago, before the finding of HCV. Hepatitis C increased from 7,000 to 13,000 deaths in 2005. Furthermore, HCV develops slowly which increases the risk for severe complications in the infected people. Identification, death, and treatment is predicted to affect 35,000 by 2030. The Center for Disease Control (CDC) used antiviral therapy with PEGylated in clinical trials. The CDC recommends a HVC one time test for people born between 1945 and 1965.They observed testing by birth. The objective of this study was to thoroughly evaluate the amount of substance abuser infected with hepatitis C in the United States. Additional to observe the treatment of HVC. Currently Medicaid and Medicare repayment standards for sofosbuvir were calculated in all states including the District of Columbia. Medicaid and Medicare covered the drug based on the following classes liver disease stage, HIV, and drug use. Approximately 42 states reimbursed the following criteria up to 74% for the drug sofobuvir. About two thirds of the United States restricted the treatment centered on prescriber type. About 88% included drug abuse in their sofosbuvir admissibility measures. Finally 50% required a dated of abstinence and 64% required drug test. The latest drug to HVC is called Sovaldi and it costs $84,000 for the 12

In time the virus can lead to cirrhosis, liver cancer and liver failure. Symptoms of HCV are jaundice (yellowing of the eyes), stomach pain, nausea and fatigue. The main problem is that many people don’t have symptoms until they already have some sort of liver damage. Treatment options for HCV include a combination of medications or depending on the degree of damage, a liver transplant. Given that HCV it is a blood disease that is spread through contact with an infected person’s blood, there are many ways to contract this disease. Injection drug users, physical altercations, sexual contact and mother to infant infection are just some of the ways this disease is spread.

Hepatitis C is a prevalent health care problem. According to the Centers of Disease Control and Prevention (CDC, 2016), approximately 2.7-3.9 million of the adult population in the United States is infected with hepatitis C virus (HCV). Some groups of people are at risk for Hepatitis C infection, including current injection drug users, people who received the blood transfusion before 1992, organ recipients from a donor who tested positive for hepatitis C virus, hemodialysis patients, and children born to a hepatitis C mother (CDC, 2016). Hepatitis C causes embarrassment and isolation from the society. Self-esteem and understanding of the family, friend and community will motivate the patient to have a good quality life in society. This

According to Baily, et al. (2009) lack of treatment to cure the disease will lead to a patient’s uncertainty on how the illness will present itself in the future. Thus, patients must face the unknown factors of their disease progression and manage life with their chronic illness. In Chronic Hepatitis C, tracking of outcomes and progressions are difficult, and disease trajectory varies from person to person (Baily, et al 2009). In addition, uncertainty stems from lack of knowledge of the disease, loss of control, and expectations of possible relapse of symptoms in the future.

Hepatitis C is definitely not a public health crisis that needs emergency intervention in terms of the policy makers being pressured to make a decision urgently. However, thousands of citizens of the United States die on a yearly basis from this contagious disease (CDC, 2014). This makes it a serious public health issue. Hepatitis C is basically a liver disease that is contagious in nature and could be fatal if left untreated. According to the CDC website over 3 million Americans are infected with the disease (HCV), and “approximately 75%–85% of people who become infected with Hepatitis C virus develop chronic infection”. Hepatitis C is most commonly transmitted in the United States through IV drug use (CDC, 2014). Other modes of transmission includes blood transfusion or coming in contact with someone’s blood, accidental needlestick injuries among health care workers (e.g., nurses and phlebotomists), sexual contact (rare) and infants born to mothers who have the disease. These above medical and demographic facts make HCV a serious threat on public health.

Hepatitis C is a prevalent health care problem. According to the Centers of Disease Control and Prevention (CDC, 2016), approximately 2.7-3.9 million of the adult population in the United States is infected with hepatitis C virus (HCV). Some groups of people are at risk for Hepatitis C infection, including current injection drug users, people who received the blood transfusion before 1992, organ recipients from a donor who tested positive for hepatitis C virus, hemodialysis patients, and children born to a hepatitis C mother (CDC, 2016). Hepatitis C causes embarrassment and isolation from the society. Self-esteem and understanding of the

Hepatitis is inflammation of the liver. There are currently five known viruses that cause can hepatitis (Microbiology, 10e). The hepatitis C virus (HCV) is transmitted through contact with the blood of an infected person; however, it is now more commonly spread among IV drug users that share needles. Healthcare workers are also at risk for contracting HCV, but with standard precautions, the risk is low. “Prior to 1992, some people acquired the HCV infection from transfusions of blood or blood products. Since 1992, all blood products have been screened for HCV, and cases of HCV due to blood transfusion now are extremely rare. HCV can be passed from mother to unborn child. Approximately 4 out of every 100 infants born to HCV-positive mothers

Hepatitis C has been referred to as a "Silent Epidemic," since it usually progresses slowly over many years. Most people who are infected with hepatitis C are not aware of any noticeable symptoms for as long as one to two decades after they are infected. In fact, by the time symptoms appear, the virus has probably already begun to damage the liver. If the liver is injured and stops functioning, death will always be the outcome (Lieber). Liver failure from chronic hepatitis C is one of the most common causes of liver transplants in the United States.